CY1106493T1 - Μεταλλαγμενη μορφη νουκλεοπρωτεϊνης ανασυνδυασμενου ιου ασθενειας του newcastle ως εμβολιο δεικτης - Google Patents

Μεταλλαγμενη μορφη νουκλεοπρωτεϊνης ανασυνδυασμενου ιου ασθενειας του newcastle ως εμβολιο δεικτης

Info

Publication number
CY1106493T1
CY1106493T1 CY20071100485T CY071100485T CY1106493T1 CY 1106493 T1 CY1106493 T1 CY 1106493T1 CY 20071100485 T CY20071100485 T CY 20071100485T CY 071100485 T CY071100485 T CY 071100485T CY 1106493 T1 CY1106493 T1 CY 1106493T1
Authority
CY
Cyprus
Prior art keywords
vaccine
indicator
disease virus
newcastle disease
mutated form
Prior art date
Application number
CY20071100485T
Other languages
English (en)
Inventor
Teshome Mebatsion
Marcus Josephus Marie Koolen
Original Assignee
Intervet International Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International Bv filed Critical Intervet International Bv
Publication of CY1106493T1 publication Critical patent/CY1106493T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μεταλλαγμένη μορφή NDV που είναι κατάλληλη ως στέλεχος εμβολίου δείκτη. Η μεταλλαγμένη μορφή NDV δεν μπορεί να εκφράσει ανοσοκυρίαρχο επιτόπιο της νουκλεοπρωτεΐνης (ΝΡ).
CY20071100485T 2000-11-02 2007-04-05 Μεταλλαγμενη μορφη νουκλεοπρωτεϊνης ανασυνδυασμενου ιου ασθενειας του newcastle ως εμβολιο δεικτης CY1106493T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00203814 2000-11-02
PCT/EP2001/012573 WO2002036617A2 (en) 2000-11-02 2001-10-30 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
EP01992717A EP1383795B1 (en) 2000-11-02 2001-10-30 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine

Publications (1)

Publication Number Publication Date
CY1106493T1 true CY1106493T1 (el) 2012-01-25

Family

ID=8172212

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100485T CY1106493T1 (el) 2000-11-02 2007-04-05 Μεταλλαγμενη μορφη νουκλεοπρωτεϊνης ανασυνδυασμενου ιου ασθενειας του newcastle ως εμβολιο δεικτης

Country Status (15)

Country Link
US (1) US7070789B2 (el)
EP (1) EP1383795B1 (el)
JP (2) JP4476543B2 (el)
AT (1) ATE352557T1 (el)
AU (2) AU2002224815B2 (el)
CA (1) CA2427578C (el)
CY (1) CY1106493T1 (el)
DE (1) DE60126349T2 (el)
DK (1) DK1383795T3 (el)
ES (1) ES2278810T3 (el)
HU (1) HU226256B1 (el)
MX (1) MXPA03003700A (el)
PL (1) PL207132B1 (el)
PT (1) PT1383795E (el)
WO (1) WO2002036617A2 (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
TW200502402A (en) 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines
US7473884B2 (en) 2005-04-21 2009-01-06 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. Orientation determination utilizing a cordless device
CN1293195C (zh) * 2005-09-02 2007-01-03 中国农业科学院哈尔滨兽医研究所 新城疫LaSota疫苗株反向遗传操作系统及其应用
CN1298845C (zh) * 2005-09-02 2007-02-07 中国农业科学院哈尔滨兽医研究所 表达禽流感病毒H5亚型HA蛋白的重组新城疫LaSota弱毒疫苗株
HUE037464T2 (hu) 2005-12-02 2018-08-28 Icahn School Med Mount Sinai Nem-natív felületi fehérjéket prezentáló kiméra Newcastle disease vírusok és alkalmazásuk
JP5432703B2 (ja) 2006-03-15 2014-03-05 インターベツト・インターナシヨナル・ベー・ベー 組み換えモノネガウイルス目ウイルスベクター
CA2638975A1 (en) * 2006-03-15 2007-09-20 Intervet International B.V. Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus
US7796119B2 (en) 2006-04-03 2010-09-14 Avago Technologies General Ip (Singapore) Pte. Ltd. Position determination with reference
US20080008736A1 (en) * 2006-07-06 2008-01-10 Thierry Glauser Random copolymers of methacrylates and acrylates
KR100801180B1 (ko) * 2006-09-26 2008-02-05 주식회사 고려비엔피 약독화된 재조합 뉴캐슬병 바이러스 및 이를 함유하는뉴캐슬병 백신
JP5554231B2 (ja) * 2007-06-13 2014-07-23 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション トリの生産形質の改変
EP2085092A1 (en) 2008-01-29 2009-08-05 Bayer Schering Pharma Aktiengesellschaft Attenuated oncolytic paramyxoviruses encoding avian cytokines
US20090246226A1 (en) * 2008-03-28 2009-10-01 Zeon Corporation Avian vaccines possessing a positive marker gene
EP2328928A2 (en) * 2008-08-25 2011-06-08 Dana-Farber Cancer Institute, Inc. Conserved influenza hemagglutinin epitope and antibodies thereto
PL3210622T3 (pl) * 2009-08-21 2021-06-28 Boehringer Ingelheim Animal Health USA Inc. Szczepionka z rekombinowanym paramyksowirusem ptaków oraz sposób jej wytwarzania i zastosowania
ES2380289T3 (es) 2009-11-30 2012-05-10 United Cancer Research Institute Nuevo clon del virus de la enfermedad de Newcastle, su fabricación y aplicación en el tratamiento médico del cáncer
KR20120101572A (ko) * 2009-12-28 2012-09-13 메리얼 리미티드 재조합 ｎｄｖ 항원 및 이의 용도
CN107630008B (zh) * 2016-07-14 2021-01-26 中国农业大学 基因ⅶ型新城疫病毒标记疫苗株及其应用
CN108956986B (zh) * 2018-05-24 2021-07-02 苏州优迪生物科技有限公司 新城疫病毒抗体检测试剂盒
CN112111467B (zh) * 2020-09-27 2021-06-22 湖北省农业科学院畜牧兽医研究所 一种基因vii型新城疫标记疫苗株及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0974660A1 (en) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
US6146642A (en) * 1998-09-14 2000-11-14 Mount Sinai School Of Medicine, Of The City University Of New York Recombinant new castle disease virus RNA expression systems and vaccines

Also Published As

Publication number Publication date
PT1383795E (pt) 2007-04-30
AU2481502A (en) 2002-05-15
HU226256B1 (en) 2008-07-28
HUP0302265A2 (hu) 2003-10-28
PL365987A1 (en) 2005-01-24
CA2427578A1 (en) 2002-05-10
ES2278810T3 (es) 2007-08-16
US7070789B2 (en) 2006-07-04
ATE352557T1 (de) 2007-02-15
MXPA03003700A (es) 2004-05-04
DE60126349T2 (de) 2007-05-31
DK1383795T3 (da) 2007-05-29
WO2002036617A3 (en) 2003-10-23
WO2002036617A2 (en) 2002-05-10
DE60126349D1 (de) 2007-03-15
EP1383795A2 (en) 2004-01-28
CA2427578C (en) 2011-09-06
US20040043035A1 (en) 2004-03-04
EP1383795B1 (en) 2007-01-24
PL207132B1 (pl) 2010-11-30
JP4476543B2 (ja) 2010-06-09
AU2002224815B2 (en) 2006-10-12
HUP0302265A3 (en) 2005-11-28
JP2010145412A (ja) 2010-07-01
JP2004517612A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
CY1106493T1 (el) Μεταλλαγμενη μορφη νουκλεοπρωτεϊνης ανασυνδυασμενου ιου ασθενειας του newcastle ως εμβολιο δεικτης
EA200100057A1 (ru) Инфекционные клоны вируса ньюкаслской болезни, вакцины и диагностические анализы
MX9207113A (es) Fragmento de adn, peptido que comprende una proteina superficial ha de un virus de gripe a y vacuna que comprende tal peptido.
Wang et al. Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand
CY1108930T1 (el) Συνθεση εμβολιου της γριπης
NZ595736A (en) Chimeric viruses presenting non-native surface proteins and uses thereof
CY1108106T1 (el) Χειμερικα μορια l1 ανθρωπινου θηλωματοϊου (hpv) και χρησεις τους
AR056133A1 (es) Virus de influenza canina y composiciones relacionadas y metodos de uso
DE69824013D1 (de) Impfstoff gegen hpv
ES8505719A1 (es) Procedimiento de preparar mutantes de delecion vivos y metodo de preparar vacunas
NO20023829L (no) Proteosom influensavaksine
ATE376059T1 (de) Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
ATE471335T1 (de) Impfstoffe gegen infektionen mit dem humanen zytomegalivirus auf grundlage von codonoptimierten polynukleotiden
CY1107570T1 (el) Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους
DK0677114T3 (da) Rekombinant svinekoppevirus
ATE254474T1 (de) Impfstoffzusammensetzung gegen herpes simplex virus und methoden zur verwendung
CY1112658T1 (el) Εμβολια τα οποια περιεχουν αντιγονο μαgε συνδεομενο με θραυσμα πρωτεϊνης d
CY1118573T1 (el) Χρηση ενος τροποποιημενου ιου ευλογιας για την ταχεια επαγωγη ανοσιας εναντι ενος ιου ευλογιας ή αλλων μολυσματικων παραγοντων
DK1425404T3 (da) Vaccinia-MVA-E3L-mutanter og anvendelse deraf
AR057225A1 (es) Vacunas marcadas contra el virus de la diarrea virica bovina
AR051853A1 (es) Vacuna para aumentar el crecimiento basada en epitopes neutralizantes
BR0206653A (pt) Esteróides 11-halogenados 7-substituìdos androgênicos
BR9915703A (pt) Mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva
HUP0302559A2 (hu) Fluorgyanta csőmásoló és nyomtató rögzítő elemeihez
DE60120840D1 (de) Impfstoffe basierend auf Mutanten des Virus der infektiösen Bursal-Krankheit